Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07373509 · ClinicalTrials.gov registry record
Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test
A clinical trial of TBI (Traumatic Brain Injury) and Implementation Research, sponsored by Shawn Eagle.
- Recruiting
- Registry status
- 340
- Enrollment target
- 1
- Study location
NCT07373509: Recruiting study of TBI (Traumatic Brain Injury) and Implementation Research, sponsored by Shawn Eagle.
NCT07373509 is a study of TBI (Traumatic Brain Injury) and Implementation Research that is actively recruiting participants, run by Shawn Eagle. The registered enrollment target is 340 participants, above the 156-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (118% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07373509, a study of TBI (Traumatic Brain Injury) and Implementation Research, is actively recruiting participants, sponsored by Shawn Eagle.
- RECRUITING
- Registry status
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to identify determinants for implementing the i-STAT Alinity whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. The main questions it aims to answer are: 1. Determine the number of patients with non-elevated (i.e., below clinical cutoff) whole blood iSTAT Alinity tests who also receive CT scans. 2. What are the obstacles for using the i-STAT Alinity for its FDA-indicated use
Primary Outcome
Rate of CTs completed for ED patient participants with a non-elevated i-STAT Alinity whole blood TBI test result.
Conditions Studied
Interventions
- DEVICE i-STAT Alinity TBI test
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2030-04 |
What NCT07373509 shows while recruiting
NCT07373509 is an observational study that tracks outcomes without assigning an intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, above the 156-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (118% higher).
The record links to 2 conditions, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which i-STAT Alinity TBI test is the first listed.
NCT07373509 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07373509 about?
NCT07373509 is a clinical study titled "Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test". The objective of this study is to identify determinants for implementing the i-STAT Alinity whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. The main questions it aims to answer...
What is the current status of trial NCT07373509?
This trial is currently recruiting. The enrollment target is 340 participants. The study started on 2026-01-13. Estimated completion is 2030-04.
What conditions does trial NCT07373509 study?
This clinical trial studies the following conditions: TBI (Traumatic Brain Injury), Implementation Research.
What interventions are being tested in trial NCT07373509?
The interventions under investigation include: i-STAT Alinity TBI test (DEVICE).
Who is sponsoring clinical trial NCT07373509?
This trial is sponsored by Shawn Eagle, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07373509 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for TBI (Traumatic Brain Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07373509's enrollment target sits among peer trials
340 4th of 20 higher than 17 of 20 other TBI (Traumatic Brain Injury) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stimulating After Recovery From Traumatic Brain Injury
RECRUITING · Early Phase 1
-
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
RECRUITING · NA
-
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Well-being Interventions in Adults With TBI
RECRUITING · NA
-
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Decision-Making Fatigue After Traumatic Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI